20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T12927 | SK1-IN-1 | S1P Receptor | |
SK1-IN-1 is a potent inhibitor of sphingosine kinase 1 (SPHK1)(IC50 of 58 nM). | |||
T30485 | SK1-I | BML 258,BML-258,BML258,BML-258 HCl | |
BML-258 HCl was removed and discontinued. | |||
T60798 | SK1- I hydrochloride | ||
SK1-I hydrochloride (BML-258 hydrochloride) is a sphingosine analog that can enhance autophagy and has antitumor activity. SK1-I hydrochloride is an isozyme-specific competitive SPHK1 inhibitor (Ki = 10 μM) [1] [2]. | |||
T12256 | NS8593 hydrochloride | NS8593 HCl | Potassium Channel |
NS8593 hydrochloride (NS8593 HCl) is a potent and selective inhibitor of small conductance Ca2+-activated K+ channels (SK channels) . | |||
T6085 | PF-543 | Sphingosine Kinase 1 Inhibitor II,PF 543 | Apoptosis , S1P Receptor , Autophagy , LPL Receptor |
PF-543 (Sphingosine Kinase 1 Inhibitor II), a novel sphingosine-competitive inhibitor of SphK1, inhibits SphK1 with IC50 and Ki of 2.0 nM and 3.6 nM. | |||
T8840 | PF-543 hydrochloride | PF-543 | Apoptosis , S1P Receptor , Autophagy , LPL Receptor |
PF-543 hydrochloride (PF-543) inhibits SphK1 with a K(i) of 3.6 nM, is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform. | |||
T9697 | ASK1-IN-1 | ASK | |
ASK1-IN-1 is an inhibitor of apoptosis signal-regulating kinase 1 which is a key mediator in the apoptotic and inflammatory cellular stress response with an IC50 of 21 nM in biochemica assays. | |||
TQ0311 | GSK163090 | Dopamine Receptor , 5-HT Receptor | |
GSK163090 is a specific and orally active 5-HT1A/B/D receptor antagonist (pKis: 9.4/8.5/9.7, and 6.3/6.7 for 5-HT1A/B/D, and dopamine D2/D3). | |||
T6003 | GSK1904529A | GSK 4529 | Apoptosis , Raf , VEGFR , IGF-1R , Syk |
GSK1904529A (GSK 4529) is a specific inhibitor of IGF-1R (IC50=27 nM) and IR(IC50=25 nM) . | |||
T3079 | GSK1838705A | IGF-1R , JNK , S6 Kinase , ALK | |
GSK1838705A is an effective IGF-1R inhibitor (IC50: 2.0 nM), modestly potent to IR (IC50: 1.6 nM) and ALK (IC50: 0.5 nM), respectively, and little inhibition to other protein kinases. | |||
T67857 | ASK1-IN-4 | ASK | |
ASK1-IN-4 is an ASK1 inhibitor, IC50 = 0.2 μM. | |||
T5427 | GSK1940029 | SCD inhibitor 1 | Dehydrogenase , Stearoyl-CoA Desaturase (SCD) |
GSK1940029 (SCD inhibitor 1) is a stearoyl-coa desaturase (SCD) inhibitor. | |||
T2357 | GSK1059615 | GSK 1059615,GSK-1059615 | Apoptosis , PI3K , mTOR |
GSK1059615 has been used in trials studying the treatment of Lymphoma, Solid Tumours, Endometrial Cancer, Solid Tumor Cancer, and Metastatic Breast Cancer. | |||
T6848 | GSK1016790A | GSK101 | Calcium Channel , TRP/TRPV Channel |
GSK1016790A (GSK101) (GSK101) is a novel, potent activator of TRPV4 (transient receptor potential vanilloid 4) with EC50 of 34 nM in choroid plexus epithelial cells. | |||
T9377 | ASK1-IN-2 | Apoptosis , ASK , MAPK | |
ASK1-IN-2 is a potent and orally active inhibitor of apoptosis signal-regulating kinase 1 (ASK1), with an IC50 of 32.8 nM. ASK1-IN-2 can potentially be used as a therapeutic strategy for ulcerative colitis[1]. | |||
T24105 | GSK121 | GSK-121,GSK 121 | PAD |
GSK121 is an inhibitor of selective PAD4. | |||
T27453 | GSK1733953A | DG70 | Antibacterial |
GSK1733953A can be used as a small molecule Mycobacterium tuberculosis respiration inhibitor with an inhibitory effect on MenG activity and an IC50 value of 2.6 ± 0.6 μM.GSK1733953A is a selective biphenylbenzamide with ... | |||
T2079 | GSK126 | GSK2816126A,EZH2 inhibitor | Histone Methyltransferase |
GSK126 (GSK2816126A) is a excellently specific EZH2 methyltransferase inhibitor ( IC50=9.9 nM). | |||
T3171 | GSK137647A | GSK 137647 | GPR |
GSK137647A (GSK 137647) is a selective FFA4 agonist. | |||
T2701 | GSK1292263 | GPR | |
GSK1292263 is a GPR119 agonist and has been investigated for the treatment of DIABETES MELLITUS, TYPE 2. |